David Nierengarten's Stock Ratings

Wedbush Analyst

David Nierengarten is an analyst at Wedbush. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/19/2025

Overall Average Return

9.47%

Smart Score

63.7%

Overall Average Return Percentile

62nd

Number of Ratings

296
Buy NowGet Alert
03/14/2025STROBuy Now
Sutro Biopharma
$0.90123.44%
David Nierengarten63%
$8 → $2DowngradeOutperform → NeutralGet Alert
03/06/2025FATEBuy Now
Fate Therapeutics
$0.95426.26%
David Nierengarten63%
$5 → $5ReiteratesNeutral → NeutralGet Alert
02/12/2025BCAXBuy Now
Bicara Therapeutics
$12.44149.2%
David Nierengarten63%
$31 → $31ReiteratesOutperform → OutperformGet Alert
02/12/2025SWTXBuy Now
SpringWorks Therapeutics
$49.6555.09%
David Nierengarten63%
$77 → $77ReiteratesOutperform → OutperformGet Alert
02/07/2025ANABBuy Now
AnaptysBio
$16.14147.83%
David Nierengarten63%
$40 → $40MaintainsOutperformGet Alert
02/06/2025BCAXBuy Now
Bicara Therapeutics
$12.44149.2%
David Nierengarten63%
→ $31Initiates → OutperformGet Alert
01/13/2025BPMCBuy Now
Blueprint Medicines
$89.5938.41%
David Nierengarten63%
$135 → $124ReiteratesOutperform → OutperformGet Alert
12/02/2024APGEBuy Now
Apogee Therapeutics
$39.01130.71%
David Nierengarten63%
$87 → $90MaintainsOutperformGet Alert
11/25/2024SRRKBuy Now
Scholar Rock Holding
$33.8838.72%
David Nierengarten63%
$40 → $47MaintainsOutperformGet Alert
11/18/2024CMRXBuy Now
Chimerix
$8.48-29.25%
David Nierengarten63%
$6 → $6ReiteratesOutperform → OutperformGet Alert
11/18/2024NTLABuy Now
Intellia Therapeutics
$9.2052.17%
David Nierengarten63%
$14 → $14ReiteratesNeutral → NeutralGet Alert
10/25/2024APGEBuy Now
Apogee Therapeutics
$39.01123.02%
David Nierengarten63%
$87 → $87ReiteratesOutperform → OutperformGet Alert
10/25/2024IMNMBuy Now
Immunome
$8.50288.24%
David Nierengarten63%
$33 → $33ReiteratesOutperform → OutperformGet Alert
10/24/2024CATXBuy Now
Perspective Therapeutics
$2.47709.72%
David Nierengarten63%
$20 → $20ReiteratesOutperform → OutperformGet Alert
10/22/2024NUVBBuy Now
Nuvation Bio
$1.91161.51%
David Nierengarten63%
$5 → $5ReiteratesOutperform → OutperformGet Alert
10/07/2024SRRKBuy Now
Scholar Rock Holding
$33.889.21%
David Nierengarten63%
$27 → $37MaintainsOutperformGet Alert
10/01/2024CATXBuy Now
Perspective Therapeutics
$2.47912.15%
David Nierengarten63%
→ $25Initiates → OutperformGet Alert
09/30/2024INZYBuy Now
Inozyme Pharma
$0.971440.67%
David Nierengarten63%
$15 → $15ReiteratesOutperform → OutperformGet Alert
09/26/2024ANABBuy Now
AnaptysBio
$16.14160.22%
David Nierengarten63%
$42 → $42ReiteratesOutperform → OutperformGet Alert
09/16/2024NUVLBuy Now
Nuvalent
$76.6650.01%
David Nierengarten63%
$99 → $115MaintainsOutperformGet Alert
09/11/2024NUVBBuy Now
Nuvation Bio
$1.91161.51%
David Nierengarten63%
$5 → $5ReiteratesOutperform → OutperformGet Alert
09/10/2024YMABBuy Now
Y-mAbs Therapeutics
$4.54406.61%
David Nierengarten63%
$23 → $23ReiteratesOutperform → OutperformGet Alert
09/10/2024ORICBuy Now
ORIC Pharmaceuticals
$7.63162.12%
David Nierengarten63%
$20 → $20ReiteratesOutperform → OutperformGet Alert
09/09/2024NUVLBuy Now
Nuvalent
$76.6629.14%
David Nierengarten63%
$99 → $99ReiteratesOutperform → OutperformGet Alert
09/04/2024ORKABuy Now
Oruka Therapeutics
$11.47248.74%
David Nierengarten63%
→ $40Initiates → OutperformGet Alert
09/04/2024SYREBuy Now
Spyre Therapeutics
$17.91151.26%
David Nierengarten63%
→ $45Initiates → OutperformGet Alert
08/13/2024ORICBuy Now
ORIC Pharmaceuticals
$7.63162.12%
David Nierengarten63%
$20 → $20ReiteratesOutperform → OutperformGet Alert
08/13/2024TCRXBuy Now
TScan Therapeutics
$1.59528.93%
David Nierengarten63%
$10 → $10ReiteratesOutperform → OutperformGet Alert
08/13/2024IMNMBuy Now
Immunome
$8.50288.24%
David Nierengarten63%
$33 → $33ReiteratesOutperform → OutperformGet Alert
08/13/2024ARTVBuy Now
Artiva Biotherapeutics
$4.71282.17%
David Nierengarten63%
→ $18Initiates → OutperformGet Alert
08/09/2024IRONBuy Now
Disc Medicine
$52.837.89%
David Nierengarten63%
$57 → $57ReiteratesOutperform → OutperformGet Alert
08/08/2024GBIOBuy Now
Generation Bio
$0.57777.19%
David Nierengarten63%
$5 → $5ReiteratesOutperform → OutperformGet Alert
07/26/2024INZYBuy Now
Inozyme Pharma
$0.971440.67%
David Nierengarten63%
$15 → $15ReiteratesOutperform → OutperformGet Alert
07/26/2024ARGXBuy Now
argenx
$610.00-8.2%
David Nierengarten63%
$519 → $560MaintainsOutperformGet Alert
07/23/2024KNSABuy Now
Kiniksa Pharmaceuticals
$22.6150.38%
David Nierengarten63%
$30 → $34MaintainsOutperformGet Alert
07/22/2024ARGXBuy Now
argenx
$610.00-14.92%
David Nierengarten63%
$519 → $519ReiteratesOutperform → OutperformGet Alert
07/17/2024ORICBuy Now
ORIC Pharmaceuticals
$7.63162.12%
David Nierengarten63%
$20 → $20ReiteratesOutperform → OutperformGet Alert
07/17/2024ARGXBuy Now
argenx
$610.00-14.92%
David Nierengarten63%
$519 → $519ReiteratesOutperform → OutperformGet Alert
07/01/2024ARGXBuy Now
argenx
$610.00-14.92%
David Nierengarten63%
$519 → $519ReiteratesOutperform → OutperformGet Alert
06/27/2024TSVTBuy Now
2seventy bio
$4.960.81%
David Nierengarten63%
$5 → $5ReiteratesNeutral → NeutralGet Alert
06/26/2024ARGXBuy Now
argenx
$610.00-14.92%
David Nierengarten63%
$519 → $519ReiteratesOutperform → OutperformGet Alert
05/29/2024IKNABuy Now
Ikena Oncology
$1.2856.25%
David Nierengarten63%
$8 → $2DowngradeOutperform → NeutralGet Alert
05/24/2024COGTBuy Now
Cogent Biosciences
$7.2537.93%
David Nierengarten63%
$10 → $10ReiteratesNeutral → NeutralGet Alert
05/24/2024NUVBBuy Now
Nuvation Bio
$1.91161.51%
David Nierengarten63%
$5 → $5ReiteratesOutperform → OutperformGet Alert
05/17/2024NUVLBuy Now
Nuvalent
$76.6629.14%
David Nierengarten63%
$99 → $99ReiteratesOutperform → OutperformGet Alert
05/15/2024NUVBBuy Now
Nuvation Bio
$1.91161.51%
David Nierengarten63%
$5 → $5ReiteratesOutperform → OutperformGet Alert
05/14/2024STROBuy Now
Sutro Biopharma
$0.90793.75%
David Nierengarten63%
$8 → $8ReiteratesOutperform → OutperformGet Alert
05/14/2024IKNABuy Now
Ikena Oncology
$1.28525%
David Nierengarten63%
$8 → $8ReiteratesOutperform → OutperformGet Alert
05/14/2024GBIOBuy Now
Generation Bio
$0.57777.19%
David Nierengarten63%
$5 → $5ReiteratesOutperform → OutperformGet Alert
05/10/2024VORBuy Now
Vor Biopharma
$0.881150%
David Nierengarten63%
$11 → $11ReiteratesOutperform → OutperformGet Alert
05/10/2024ANABBuy Now
AnaptysBio
$16.14110.66%
David Nierengarten63%
→ $34ReiteratesOutperform → OutperformGet Alert
05/10/2024XNCRBuy Now
Xencor
$12.52187.54%
David Nierengarten63%
$34 → $36MaintainsOutperformGet Alert
05/10/2024FATEBuy Now
Fate Therapeutics
$0.95426.26%
David Nierengarten63%
$7 → $5MaintainsNeutralGet Alert
05/06/2024FATEBuy Now
Fate Therapeutics
$0.95636.76%
David Nierengarten63%
$7 → $7ReiteratesNeutral → NeutralGet Alert
04/26/2024BPMCBuy Now
Blueprint Medicines
$89.5922.78%
David Nierengarten63%
$110 → $110ReiteratesOutperform → OutperformGet Alert
04/23/2024BEAMBuy Now
Beam Therapeutics
$22.75150.55%
David Nierengarten63%
$57 → $57ReiteratesOutperform → OutperformGet Alert
04/23/2024VORBuy Now
Vor Biopharma
$0.881150%
David Nierengarten63%
$11 → $11ReiteratesOutperform → OutperformGet Alert
04/23/2024TCRXBuy Now
TScan Therapeutics
$1.59528.93%
David Nierengarten63%
$10 → $10ReiteratesOutperform → OutperformGet Alert
04/23/2024PRMEBuy Now
Prime Medicine
$1.80566.67%
David Nierengarten63%
$12 → $12ReiteratesOutperform → OutperformGet Alert
04/23/2024FATEBuy Now
Fate Therapeutics
$0.95636.76%
David Nierengarten63%
$7 → $7ReiteratesNeutral → NeutralGet Alert
04/23/2024NTLABuy Now
Intellia Therapeutics
$9.20215.22%
David Nierengarten63%
$29 → $29ReiteratesNeutral → NeutralGet Alert
04/18/2024ARGXBuy Now
argenx
$610.00-14.59%
David Nierengarten63%
$521 → $521ReiteratesOutperform → OutperformGet Alert
04/03/2024PRMEBuy Now
Prime Medicine
$1.80566.67%
David Nierengarten63%
→ $12Initiates → OutperformGet Alert
04/02/2024PRMEBuy Now
Prime Medicine
$1.80566.67%
David Nierengarten63%
→ $12Initiates → OutperformGet Alert
04/01/2024IMNMBuy Now
Immunome
$8.50288.24%
David Nierengarten63%
$27 → $33MaintainsOutperformGet Alert
03/26/2024STROBuy Now
Sutro Biopharma
$0.90793.75%
David Nierengarten63%
$12 → $8MaintainsOutperformGet Alert
03/21/2024FUSNBuy Now
Fusion Pharmaceuticals
——
David Nierengarten63%
$24 → $24ReiteratesNeutral → NeutralGet Alert
03/21/2024VORBuy Now
Vor Biopharma
$0.881150%
David Nierengarten63%
$11 → $11ReiteratesOutperform → OutperformGet Alert
03/19/2024BLUEBuy Now
bluebird bio
$3.94-57.36%
David Nierengarten63%
$60 → $33.6MaintainsNeutralGet Alert
03/19/2024FUSNBuy Now
Fusion Pharmaceuticals
——
David Nierengarten63%
→ $24DowngradeOutperform → NeutralGet Alert
03/18/2024TSVTBuy Now
2seventy bio
$4.960.81%
David Nierengarten63%
$5 → $5ReiteratesNeutral → NeutralGet Alert
03/12/2024ORICBuy Now
ORIC Pharmaceuticals
$7.63162.12%
David Nierengarten63%
$20 → $20ReiteratesOutperform → OutperformGet Alert
03/12/2024ANABBuy Now
AnaptysBio
$16.14—
David Nierengarten63%
$20 → $34UpgradeNeutral → OutperformGet Alert
03/07/2024GBIOBuy Now
Generation Bio
$0.57777.19%
David Nierengarten63%
$5 → $5ReiteratesOutperform → OutperformGet Alert
03/01/2024NUVBBuy Now
Nuvation Bio
$1.91161.51%
David Nierengarten63%
$5 → $5ReiteratesOutperform → OutperformGet Alert
03/01/2024ORICBuy Now
ORIC Pharmaceuticals
$7.63162.12%
David Nierengarten63%
$12 → $20MaintainsOutperformGet Alert
02/29/2024MRSNBuy Now
Mersana Therapeutics
$0.471392.54%
David Nierengarten63%
$2 → $7UpgradeNeutral → OutperformGet Alert
02/28/2024XNCRBuy Now
Xencor
$12.52171.57%
David Nierengarten63%
$36 → $34MaintainsOutperformGet Alert
02/27/2024FATEBuy Now
Fate Therapeutics
$0.95636.76%
David Nierengarten63%
$3 → $7MaintainsNeutralGet Alert
02/26/2024SWTXBuy Now
SpringWorks Therapeutics
$49.6540.99%
David Nierengarten63%
$60 → $70MaintainsOutperformGet Alert
02/23/2024COGTBuy Now
Cogent Biosciences
$7.2537.93%
David Nierengarten63%
$5 → $10MaintainsNeutralGet Alert
02/13/2024GTHXBuy Now
G1 Therapeutics
——
David Nierengarten63%
$5 → $4MaintainsOutperformGet Alert
02/01/2024TCRXBuy Now
TScan Therapeutics
$1.59466.04%
David Nierengarten63%
$9 → $9ReiteratesOutperform → OutperformGet Alert
01/30/2024INZYBuy Now
Inozyme Pharma
$0.971440.67%
David Nierengarten63%
$15 → $15ReiteratesOutperform → OutperformGet Alert
01/26/2024FUSNBuy Now
Fusion Pharmaceuticals
——
David Nierengarten63%
$13 → $13ReiteratesOutperform → OutperformGet Alert
01/23/2024IMNMBuy Now
Immunome
$8.50123.53%
David Nierengarten63%
$12 → $19MaintainsOutperformGet Alert
01/19/2024IKNABuy Now
Ikena Oncology
$1.28525%
David Nierengarten63%
$8 → $8ReiteratesOutperform → OutperformGet Alert
01/18/2024VORBuy Now
Vor Biopharma
$0.881150%
David Nierengarten63%
$11 → $11ReiteratesOutperform → OutperformGet Alert
01/17/2024KNTEBuy Now
Kinnate Biopharma
——
David Nierengarten63%
$2 → $2ReiteratesNeutral → NeutralGet Alert
01/02/2024KNSABuy Now
Kiniksa Pharmaceuticals
$22.6110.57%
David Nierengarten63%
$23 → $25MaintainsOutperformGet Alert
12/19/2023IMNMBuy Now
Immunome
$8.5041.18%
David Nierengarten63%
→ $12Initiates → OutperformGet Alert
12/11/2023COGTBuy Now
Cogent Biosciences
$7.25-31.03%
David Nierengarten63%
$20 → $5DowngradeOutperform → NeutralGet Alert
12/08/2023MAXNBuy Now
Maxeon Solar Technologies
$4.0324.07%
David Nierengarten63%
$1400 → $500MaintainsEqual-WeightGet Alert
11/29/2023ANABBuy Now
AnaptysBio
$16.1423.92%
David Nierengarten63%
→ $20ReiteratesNeutral → NeutralGet Alert
11/20/2023TSVTBuy Now
2seventy bio
$4.96-59.68%
David Nierengarten63%
→ $2DowngradeOutperform → NeutralGet Alert
11/10/2023GBIOBuy Now
Generation Bio
$0.571478.95%
David Nierengarten63%
$11 → $9MaintainsOutperformGet Alert
11/09/2023FATEBuy Now
Fate Therapeutics
$0.95215.76%
David Nierengarten63%
$6 → $3MaintainsNeutralGet Alert
11/08/2023XNCRBuy Now
Xencor
$12.52187.54%
David Nierengarten63%
$37 → $36MaintainsOutperformGet Alert
11/03/2023ANABBuy Now
AnaptysBio
$16.1423.92%
David Nierengarten63%
$18 → $20MaintainsNeutralGet Alert
10/30/2023GTHXBuy Now
G1 Therapeutics
——
David Nierengarten63%
→ $5ReiteratesOutperform → OutperformGet Alert
10/23/2023STROBuy Now
Sutro Biopharma
$0.901240.63%
David Nierengarten63%
→ $12ReiteratesOutperform → OutperformGet Alert
10/23/2023ORICBuy Now
ORIC Pharmaceuticals
$7.6383.49%
David Nierengarten63%
→ $14ReiteratesOutperform → OutperformGet Alert
10/18/2023FRLNBuy Now
Freeline Therapeutics
——
David Nierengarten63%
$8 → $5DowngradeOutperform → NeutralGet Alert
10/18/2023ITOSBuy Now
ITeos Therapeutics
$7.09365.44%
David Nierengarten63%
→ $33ReiteratesOutperform → OutperformGet Alert
09/22/2023ORICBuy Now
ORIC Pharmaceuticals
$7.6383.49%
David Nierengarten63%
→ $14Initiates → OutperformGet Alert
09/22/2023IKNABuy Now
Ikena Oncology
$1.28759.38%
David Nierengarten63%
→ $11Initiates → OutperformGet Alert
09/19/2023KNTEBuy Now
Kinnate Biopharma
——
David Nierengarten63%
$14 → $2DowngradeOutperform → NeutralGet Alert
09/08/2023INZYBuy Now
Inozyme Pharma
$0.971440.67%
David Nierengarten63%
→ $15MaintainsOutperformGet Alert
08/17/2023CMRXBuy Now
Chimerix
$8.48-29.25%
David Nierengarten63%
→ $6ReiteratesOutperform → OutperformGet Alert
08/11/2023STROBuy Now
Sutro Biopharma
$0.901240.63%
David Nierengarten63%
$20 → $12MaintainsOutperformGet Alert
08/11/2023VORBuy Now
Vor Biopharma
$0.881150%
David Nierengarten63%
$18 → $11MaintainsOutperformGet Alert
08/10/2023SRRKBuy Now
Scholar Rock Holding
$33.88-29.16%
David Nierengarten63%
→ $24ReiteratesOutperform → OutperformGet Alert
08/08/2023ANABBuy Now
AnaptysBio
$16.1461.09%
David Nierengarten63%
$29 → $26MaintainsNeutralGet Alert
08/08/2023APGEBuy Now
Apogee Therapeutics
$39.012.54%
David Nierengarten63%
→ $40Initiates → OutperformGet Alert
08/03/2023GBIOBuy Now
Generation Bio
$0.571829.82%
David Nierengarten63%
→ $11ReiteratesOutperform → OutperformGet Alert
08/03/2023GTHXBuy Now
G1 Therapeutics
——
David Nierengarten63%
→ $5ReiteratesOutperform → OutperformGet Alert
07/28/2023TSVTBuy Now
2seventy bio
$4.96343.55%
David Nierengarten63%
$26 → $22MaintainsOutperformGet Alert
07/27/2023MRSNBuy Now
Mersana Therapeutics
$0.47326.44%
David Nierengarten63%
$12 → $2DowngradeOutperform → NeutralGet Alert
07/26/2023KPTIBuy Now
Karyopharm Therapeutics
$5.83-31.39%
David Nierengarten63%
$105 → $60MaintainsNeutralGet Alert
07/20/2023NUVLBuy Now
Nuvalent
$76.66-30.86%
David Nierengarten63%
→ $53ReiteratesOutperform → OutperformGet Alert
07/18/2023ARGXBuy Now
argenx
$610.00-6.56%
David Nierengarten63%
→ $570ReiteratesOutperform → OutperformGet Alert
07/14/2023THRXBuy Now
Theseus Pharmaceuticals
——
David Nierengarten63%
$24 → $7MaintainsOutperformGet Alert
07/13/2023SRRKBuy Now
Scholar Rock Holding
$33.88-29.16%
David Nierengarten63%
→ $24ReiteratesOutperform → OutperformGet Alert
07/12/2023AVROBuy Now
Avrobio
——
David Nierengarten63%
→ $24DowngradeOutperform → NeutralGet Alert
06/28/2023FUSNBuy Now
Fusion Pharmaceuticals
——
David Nierengarten63%
→ $13ReiteratesOutperform → OutperformGet Alert
06/22/2023TCRXBuy Now
TScan Therapeutics
$1.59403.14%
David Nierengarten63%
→ $8Initiates → OutperformGet Alert
06/21/2023ARGXBuy Now
argenx
$610.00-25.57%
David Nierengarten63%
→ $454ReiteratesOutperform → OutperformGet Alert
06/07/2023NVCRBuy Now
NovoCure
$19.36137.6%
David Nierengarten63%
$53 → $46UpgradeUnderperform → NeutralGet Alert
05/18/2023TSVTBuy Now
2seventy bio
$4.96424.19%
David Nierengarten63%
→ $26ReiteratesOutperform → OutperformGet Alert
05/15/2023TSVTBuy Now
2seventy bio
$4.96424.19%
David Nierengarten63%
→ $26ReiteratesOutperform → OutperformGet Alert
05/12/2023VORBuy Now
Vor Biopharma
$0.881945.45%
David Nierengarten63%
→ $18ReiteratesOutperform → OutperformGet Alert
05/12/2023KNTEBuy Now
Kinnate Biopharma
——
David Nierengarten63%
→ $14ReiteratesOutperform → OutperformGet Alert
05/12/2023ANABBuy Now
AnaptysBio
$16.1479.68%
David Nierengarten63%
→ $29ReiteratesNeutral → NeutralGet Alert
05/10/2023YMABBuy Now
Y-mAbs Therapeutics
$4.54186.34%
David Nierengarten63%
$5 → $13UpgradeNeutral → OutperformGet Alert
05/09/2023XNCRBuy Now
Xencor
$12.52195.53%
David Nierengarten63%
$39 → $37MaintainsOutperformGet Alert
05/01/2023ISEEBuy Now
IVERIC bio
——
David Nierengarten63%
$35 → $40DowngradeOutperform → NeutralGet Alert
04/26/2023IRONBuy Now
Disc Medicine
$52.83-31.86%
David Nierengarten63%
$32 → $36MaintainsOutperformGet Alert
04/21/2023ARGXBuy Now
argenx
$610.00-29.18%
David Nierengarten63%
→ $432Reiterates → OutperformGet Alert
04/03/2023ISEEBuy Now
IVERIC bio
——
David Nierengarten63%
→ $29Reiterates → OutperformGet Alert
03/31/2023STROBuy Now
Sutro Biopharma
$0.902134.39%
David Nierengarten63%
→ $20Reiterates → OutperformGet Alert
03/17/2023TSVTBuy Now
2seventy bio
$4.96323.39%
David Nierengarten63%
$28 → $21MaintainsOutperformGet Alert
03/16/2023KNTEBuy Now
Kinnate Biopharma
——
David Nierengarten63%
$29 → $25MaintainsOutperformGet Alert
03/16/2023NUVBBuy Now
Nuvation Bio
$1.91161.51%
David Nierengarten63%
→ $5Reiterates → OutperformGet Alert
03/16/2023ITOSBuy Now
ITeos Therapeutics
$7.09365.44%
David Nierengarten63%
$45 → $33MaintainsOutperformGet Alert
02/24/2023GBIOBuy Now
Generation Bio
$0.572531.58%
David Nierengarten63%
$24 → $15MaintainsOutperformGet Alert
01/26/2023MGTABuy Now
Magenta Therapeutics
——
David Nierengarten63%
—DowngradeOutperform → NeutralGet Alert
01/18/2023NUVLBuy Now
Nuvalent
$76.66-49.13%
David Nierengarten63%
→ $39Initiates → OutperformGet Alert
01/06/2023FATEBuy Now
Fate Therapeutics
$0.95636.76%
David Nierengarten63%
→ $7DowngradeOutperform → NeutralGet Alert
01/04/2023IRONBuy Now
Disc Medicine
$52.83-43.21%
David Nierengarten63%
→ $30Initiates → OutperformGet Alert
10/31/2022YMABBuy Now
Y-mAbs Therapeutics
$4.5432.16%
David Nierengarten63%
→ $6DowngradeOutperform → NeutralGet Alert
10/24/2022AGTCBuy Now
Applied Genetic Techs
——
David Nierengarten63%
—DowngradeOutperform → NeutralGet Alert
09/26/2022FENCBuy Now
Fennec Pharmaceuticals
$6.57189.19%
David Nierengarten63%
$11 → $19MaintainsOutperformGet Alert
09/16/2022GTHXBuy Now
G1 Therapeutics
——
David Nierengarten63%
$20 → $25MaintainsOutperformGet Alert
07/26/2022VORBuy Now
Vor Biopharma
$0.881945.45%
David Nierengarten63%
→ $18Initiates → OutperformGet Alert
06/27/2022EPZMBuy Now
Epizyme
——
David Nierengarten63%
—DowngradeOutperform → NeutralGet Alert
06/03/2022TPTXBuy Now
Turning Point
——
David Nierengarten63%
$61 → $76DowngradeOutperform → NeutralGet Alert
05/27/2022SWTXBuy Now
SpringWorks Therapeutics
$49.650.7%
David Nierengarten63%
$110 → $50MaintainsOutperformGet Alert
03/16/2022INZYBuy Now
Inozyme Pharma
$0.972467.79%
David Nierengarten63%
$35 → $25MaintainsOutperformGet Alert
02/22/2022CDAKBuy Now
Codiak BioSciences
——
David Nierengarten63%
$34 → $24MaintainsOutperformGet Alert
01/10/2022SRRKBuy Now
Scholar Rock Holding
$33.8847.58%
David Nierengarten63%
$66 → $50MaintainsOutperformGet Alert
12/15/2021FATEBuy Now
Fate Therapeutics
$0.957688.65%
David Nierengarten63%
$71 → $74UpgradeNeutral → OutperformGet Alert
12/14/2021GBIOBuy Now
Generation Bio
$0.575338.6%
David Nierengarten63%
$36 → $31MaintainsOutperformGet Alert
11/08/2021TSVTBuy Now
2seventy bio
$4.96706.45%
David Nierengarten63%
→ $40Initiates → OutperformGet Alert
11/01/2021THRXBuy Now
Theseus Pharmaceuticals
——
David Nierengarten63%
→ $24Initiates → OutperformGet Alert
09/17/2021TCRRBuy Now
TCR2 Therapeutics
——
David Nierengarten63%
$45 → $11DowngradeOutperform → NeutralGet Alert
07/22/2021ARGXBuy Now
argenx
$610.00-40.66%
David Nierengarten63%
$344 → $362MaintainsOutperformGet Alert
07/14/2021GBIOBuy Now
Generation Bio
$0.576215.79%
David Nierengarten63%
$40 → $36MaintainsOutperformGet Alert
06/29/2021BEAMBuy Now
Beam Therapeutics
$22.75554.95%
David Nierengarten63%
$114 → $149MaintainsOutperformGet Alert
06/28/2021NTLABuy Now
Intellia Therapeutics
$9.20845.65%
David Nierengarten63%
$73 → $87MaintainsNeutralGet Alert
06/08/2021ARGXBuy Now
argenx
$610.00-43.61%
David Nierengarten63%
$356 → $344MaintainsOutperformGet Alert
04/14/2021NVCRBuy Now
NovoCure
$19.36695.45%
David Nierengarten63%
$159 → $154DowngradeNeutral → UnderperformGet Alert
03/31/2021CMRXBuy Now
Chimerix
$8.4865.09%
David Nierengarten63%
→ $14Initiates → OutperformGet Alert
03/09/2021ANABBuy Now
AnaptysBio
$16.14—
David Nierengarten63%
—DowngradeOutperform → NeutralGet Alert
03/08/2021NUVBBuy Now
Nuvation Bio
$1.91946.03%
David Nierengarten63%
→ $20Initiates → OutperformGet Alert
02/26/2021FATEBuy Now
Fate Therapeutics
$0.95—
David Nierengarten63%
—DowngradeOutperform → NeutralGet Alert
11/10/2020SRRKBuy Now
Scholar Rock Holding
$33.8838.72%
David Nierengarten63%
$33 → $47MaintainsOutperformGet Alert
11/09/2020CDAKBuy Now
Codiak BioSciences
——
David Nierengarten63%
→ $19Initiates → OutperformGet Alert
10/27/2020SRRKBuy Now
Scholar Rock Holding
$33.88-2.6%
David Nierengarten63%
$23 → $33MaintainsOutperformGet Alert
10/27/2020ANABBuy Now
AnaptysBio
$16.14116.85%
David Nierengarten63%
$20 → $35UpgradeNeutral → OutperformGet Alert
10/06/2020MYOKBuy Now
MyoKardia
——
David Nierengarten63%
$127 → $225DowngradeOutperform → NeutralGet Alert
09/01/2020FRLNBuy Now
Freeline Therapeutics
——
David Nierengarten63%
→ $420Initiates → OutperformGet Alert
08/18/2020INZYBuy Now
Inozyme Pharma
$0.973494.91%
David Nierengarten63%
→ $35Initiates → OutperformGet Alert
08/13/2020SWTXBuy Now
SpringWorks Therapeutics
$49.650.7%
David Nierengarten63%
$48 → $50MaintainsOutperformGet Alert
08/06/2020GTHXBuy Now
G1 Therapeutics
——
David Nierengarten63%
$50 → $46MaintainsOutperformGet Alert
07/21/2020FUSNBuy Now
Fusion Pharmaceuticals
——
David Nierengarten63%
→ $25Initiates → OutperformGet Alert
07/07/2020UMRXBuy Now
Unum Therapeutics
——
David Nierengarten63%
$1 → $4UpgradeNeutral → OutperformGet Alert
06/23/2020KPTIBuy Now
Karyopharm Therapeutics
$5.83345.97%
David Nierengarten63%
$375 → $390MaintainsNeutralGet Alert
05/13/2020SWTXBuy Now
SpringWorks Therapeutics
$49.65-3.32%
David Nierengarten63%
$45 → $48MaintainsOutperformGet Alert
05/05/2020STMLBuy Now
Stemline Therapeutics
——
David Nierengarten63%
$11 → $12.5DowngradeOutperform → NeutralGet Alert
05/01/2020NVCRBuy Now
NovoCure
$19.36302.89%
David Nierengarten63%
$80 → $78MaintainsNeutralGet Alert
04/03/2020FATEBuy Now
Fate Therapeutics
$0.954215.34%
David Nierengarten63%
$38 → $41MaintainsOutperformGet Alert
03/17/2020STMLBuy Now
Stemline Therapeutics
——
David Nierengarten63%
$14 → $11MaintainsOutperformGet Alert
03/04/2020UMRXBuy Now
Unum Therapeutics
——
David Nierengarten63%
$7 → $1DowngradeOutperform → NeutralGet Alert
03/02/2020BEAMBuy Now
Beam Therapeutics
$22.7540.66%
David Nierengarten63%
→ $32Initiates → OutperformGet Alert
02/27/2020GTHXBuy Now
G1 Therapeutics
——
David Nierengarten63%
$67 → $55MaintainsOutperformGet Alert
02/14/2020FATEBuy Now
Fate Therapeutics
$0.953373.32%
David Nierengarten63%
$29 → $33MaintainsOutperformGet Alert
02/14/2020RAREBuy Now
Ultragenyx Pharmaceutical
$38.8693%
David Nierengarten63%
$71 → $75MaintainsOutperformGet Alert
02/14/2020NTLABuy Now
Intellia Therapeutics
$9.2073.91%
David Nierengarten63%
$21 → $16DowngradeOutperform → NeutralGet Alert
01/24/2020EPZMBuy Now
Epizyme
——
David Nierengarten63%
$24 → $30MaintainsOutperformGet Alert
01/17/2020KPTIBuy Now
Karyopharm Therapeutics
$5.83—
David Nierengarten63%
—DowngradeOutperform → NeutralGet Alert
01/17/2020SYRSBuy Now
Syros Pharmaceuticals
$0.146566.67%
David Nierengarten63%
→ $90DowngradeOutperform → NeutralGet Alert
01/16/2020STMLBuy Now
Stemline Therapeutics
——
David Nierengarten63%
$17 → $14MaintainsOutperformGet Alert
01/07/2020ISEEBuy Now
IVERIC bio
——
David Nierengarten63%
→ $13Initiates → OutperformGet Alert
12/03/2019BOLDBuy Now
Audentes Therapeutics
$1.60—
David Nierengarten63%
—DowngradeOutperform → NeutralGet Alert
11/11/2019STMLBuy Now
Stemline Therapeutics
——
David Nierengarten63%
$20 → $17MaintainsOutperformGet Alert
10/08/2019SWTXBuy Now
SpringWorks Therapeutics
$49.65-33.53%
David Nierengarten63%
→ $33Initiates → OutperformGet Alert
09/10/2019TPTXBuy Now
Turning Point
——
David Nierengarten63%
→ $63Initiates → OutperformGet Alert
08/08/2019MYOKBuy Now
MyoKardia
——
David Nierengarten63%
$87 → $90MaintainsOutperformGet Alert
08/02/2019ARGXBuy Now
argenx
$610.00-72.13%
David Nierengarten63%
$144 → $170MaintainsOutperformGet Alert
08/02/2019RAREBuy Now
Ultragenyx Pharmaceutical
$38.8693%
David Nierengarten63%
→ $75Assumes → OutperformGet Alert
07/26/2019NVCRBuy Now
NovoCure
$19.36—
David Nierengarten63%
—DowngradeOutperform → NeutralGet Alert
05/13/2019STMLBuy Now
Stemline Therapeutics
——
David Nierengarten63%
—DowngradeOutperform → NeutralGet Alert
05/03/2019NTLABuy Now
Intellia Therapeutics
$9.20—
David Nierengarten63%
—UpgradeNeutral → OutperformGet Alert
05/03/2019NTLABuy Now
Intellia Therapeutics
$9.20—
David Nierengarten63%
—UpgradeNeutral → OutperformGet Alert
03/11/2019TCRRBuy Now
TCR2 Therapeutics
——
David Nierengarten63%
→ $28Initiates → OutperformGet Alert
03/01/2019ARGXBuy Now
argenx
$610.00-76.39%
David Nierengarten63%
$131 → $144MaintainsOutperformGet Alert
02/27/2019KPTIBuy Now
Karyopharm Therapeutics
$5.832.92%
David Nierengarten63%
$210 → $90MaintainsOutperformGet Alert
02/11/2019FATEBuy Now
Fate Therapeutics
$0.952110.29%
David Nierengarten63%
$19 → $21MaintainsOutperformGet Alert
12/07/2018XNCRBuy Now
Xencor
$12.52251.44%
David Nierengarten63%
$42 → $44MaintainsOutperformGet Alert
12/04/2018ARGXBuy Now
argenx
$610.00-78.52%
David Nierengarten63%
$130 → $131MaintainsOutperformGet Alert
12/04/2018TSROBuy Now
Tesaro
——
David Nierengarten63%
$60 → $75DowngradeOutperform → NeutralGet Alert
11/09/2018KPTIBuy Now
Karyopharm Therapeutics
$5.83—
David Nierengarten63%
—UpgradeNeutral → OutperformGet Alert
11/07/2018ONCEBuy Now
Spark Therapeutics
——
David Nierengarten63%
→ $40UpgradeUnderperform → NeutralGet Alert
11/05/2018ARGXBuy Now
argenx
$610.00-78.69%
David Nierengarten63%
$125 → $130MaintainsOutperformGet Alert
11/02/2018NTLABuy Now
Intellia Therapeutics
$9.20117.39%
David Nierengarten63%
$36 → $20DowngradeOutperform → NeutralGet Alert
10/29/2018RAREBuy Now
Ultragenyx Pharmaceutical
$38.86126.45%
David Nierengarten63%
$90 → $88MaintainsOutperformGet Alert
10/22/2018STROBuy Now
Sutro Biopharma
$0.902134.39%
David Nierengarten63%
→ $20Initiates → OutperformGet Alert
10/08/2018BOLDBuy Now
Audentes Therapeutics
$1.603150%
David Nierengarten63%
$49 → $52MaintainsOutperformGet Alert
09/17/2018FENCBuy Now
Fennec Pharmaceuticals
$6.57143.53%
David Nierengarten63%
$17 → $16MaintainsOutperformGet Alert
08/30/2018RAREBuy Now
Ultragenyx Pharmaceutical
$38.86131.6%
David Nierengarten63%
$80 → $90MaintainsOutperformGet Alert
08/14/2018UMRXBuy Now
Unum Therapeutics
——
David Nierengarten63%
$18 → $20MaintainsOutperformGet Alert
08/06/2018RAREBuy Now
Ultragenyx Pharmaceutical
$38.86105.87%
David Nierengarten63%
$71 → $80MaintainsOutperformGet Alert
07/27/2018NVCRBuy Now
NovoCure
$19.36106.61%
David Nierengarten63%
$33 → $40MaintainsOutperformGet Alert
07/16/2018ECYTBuy Now
Endocyte
——
David Nierengarten63%
$15 → $21MaintainsOutperformGet Alert
06/25/2018ARGXBuy Now
argenx
$610.00-81.31%
David Nierengarten63%
$93 → $114MaintainsOutperformGet Alert
05/29/2018STMLBuy Now
Stemline Therapeutics
——
David Nierengarten63%
$20 → $22MaintainsOutperformGet Alert
05/24/2018KPTIBuy Now
Karyopharm Therapeutics
$5.83—
David Nierengarten63%
—DowngradeOutperform → NeutralGet Alert
05/11/2018VYGRBuy Now
Voyager Therapeutics
$3.88—
David Nierengarten63%
—UpgradeNeutral → OutperformGet Alert
04/27/2018NVCRBuy Now
NovoCure
$19.3670.45%
David Nierengarten63%
$29 → $33MaintainsOutperformGet Alert
04/26/2018ARGXBuy Now
argenx
$610.00-84.92%
David Nierengarten63%
$88 → $92MaintainsOutperformGet Alert
04/24/2018EPZMBuy Now
Epizyme
——
David Nierengarten63%
$24 → $20MaintainsOutperformGet Alert
04/23/2018UMRXBuy Now
Unum Therapeutics
——
David Nierengarten63%
→ $18Initiates → OutperformGet Alert
04/16/2018BPMCBuy Now
Blueprint Medicines
$89.5918.32%
David Nierengarten63%
$98 → $106MaintainsOutperformGet Alert
03/19/2018XNCRBuy Now
Xencor
$12.52211.5%
David Nierengarten63%
$38 → $39MaintainsOutperformGet Alert
03/13/2018SYRSBuy Now
Syros Pharmaceuticals
$0.149529.63%
David Nierengarten63%
$110 → $130MaintainsOutperformGet Alert
03/12/2018VYGRBuy Now
Voyager Therapeutics
$3.88—
David Nierengarten63%
—DowngradeOutperform → NeutralGet Alert
03/12/2018FENCBuy Now
Fennec Pharmaceuticals
$6.57158.75%
David Nierengarten63%
→ $17Initiates → OutperformGet Alert
03/06/2018FATEBuy Now
Fate Therapeutics
$0.951899.79%
David Nierengarten63%
$10 → $19MaintainsOutperformGet Alert
02/20/2018ANABBuy Now
AnaptysBio
$16.14835.56%
David Nierengarten63%
$142 → $151MaintainsOutperformGet Alert
01/16/2018ONCEBuy Now
Spark Therapeutics
——
David Nierengarten63%
—DowngradeNeutral → UnderperformGet Alert
11/20/2017PRTABuy Now
Prothena Corp
$12.93—
David Nierengarten63%
—DowngradeOutperform → NeutralGet Alert
10/03/2017ECYTBuy Now
Endocyte
——
David Nierengarten63%
—UpgradeNeutral → OutperformGet Alert
09/14/2017RAREBuy Now
Ultragenyx Pharmaceutical
$38.86—
David Nierengarten63%
—UpgradeNeutral → OutperformGet Alert
08/29/2017KITEBuy Now
Kite Pharma
——
David Nierengarten63%
—UpgradeUnderperform → NeutralGet Alert
08/29/2017JUNOBuy Now
Juno Therapeutics
——
David Nierengarten63%
—UpgradeNeutral → OutperformGet Alert
08/28/2017CMTABuy Now
Clementia Pharmaceuticals Inc. - Common Shares
——
David Nierengarten63%
→ $26Initiates → OutperformGet Alert
06/12/2017GTHXBuy Now
G1 Therapeutics
——
David Nierengarten63%
→ $31Initiates → OutperformGet Alert
06/05/2017ECYTBuy Now
Endocyte
——
David Nierengarten63%
—DowngradeOutperform → NeutralGet Alert
05/09/2017KITEBuy Now
Kite Pharma
——
David Nierengarten63%
—DowngradeNeutral → UnderperformGet Alert
04/19/2017RAREBuy Now
Ultragenyx Pharmaceutical
$38.8693%
David Nierengarten63%
$80 → $75DowngradeOutperform → NeutralGet Alert
03/28/2017TSROBuy Now
Tesaro
——
David Nierengarten63%
$164 → $174Reiterates → OutperformGet Alert
03/23/2017RAREBuy Now
Ultragenyx Pharmaceutical
$38.86105.87%
David Nierengarten63%
$88 → $80Reiterates → OutperformGet Alert
03/15/2017TSROBuy Now
Tesaro
——
David Nierengarten63%
$200 → $164Reiterates → OutperformGet Alert
03/09/2017ANABBuy Now
AnaptysBio
$16.1473.48%
David Nierengarten63%
→ $28Reiterates → OutperformGet Alert
02/28/2017FATEBuy Now
Fate Therapeutics
$0.95636.76%
David Nierengarten63%
→ $7Reiterates → OutperformGet Alert
02/21/2017ANABBuy Now
AnaptysBio
$16.1473.48%
David Nierengarten63%
→ $28Initiates → OutperformGet Alert
02/01/2017JUNOBuy Now
Juno Therapeutics
——
David Nierengarten63%
→ $24Initiates → NeutralGet Alert
01/27/2017NOVNBuy Now
Novan
——
David Nierengarten63%
—DowngradeOutperform → NeutralGet Alert
11/28/2016PNRABuy Now
Panera Bread
——
David Nierengarten63%
→ $220DowngradeOutperform → NeutralGet Alert
10/17/2016NOVNBuy Now
Novan
——
David Nierengarten63%
—Initiates → OutperformGet Alert
09/20/2016WCICBuy Now
WCI Communities
——
David Nierengarten63%
→ $21Initiates → NeutralGet Alert
09/12/2016VTAEBuy Now
Vitae Pharmaceuticals
——
David Nierengarten63%
—DowngradeOutperform → NeutralGet Alert
08/22/2016MDVNBuy Now
Medivation
——
David Nierengarten63%
—DowngradeOutperform → NeutralGet Alert
08/22/2016MDVNBuy Now
Medivation
——
David Nierengarten63%
→ $81.5DowngradeOutperform → NeutralGet Alert
08/18/2016CERUBuy Now
Cerulean Pharma
——
David Nierengarten63%
$900 → $100DowngradeOutperform → NeutralGet Alert
08/16/2016PSGBuy Now
Performance Sports Group
——
David Nierengarten63%
—DowngradeOutperform → NeutralGet Alert
08/15/2016BOLDBuy Now
Audentes Therapeutics
$1.601150%
David Nierengarten63%
→ $20Initiates → OutperformGet Alert
07/25/2016OUTRBuy Now
Space Acquisition Corp. I
——
David Nierengarten63%
→ $45DowngradeBuy → NeutralGet Alert
07/25/2016SYRSBuy Now
Syros Pharmaceuticals
$0.1413233.33%
David Nierengarten63%
→ $180Initiates → OutperformGet Alert
07/15/2016STJBuy Now
St Jude Medical
——
David Nierengarten63%
$70 → $84DowngradeOutperform → NeutralGet Alert
06/16/2016RLYPBuy Now
Relypsa
——
David Nierengarten63%
$51 → $51MaintainsOutperformGet Alert
06/09/2016RLYPBuy Now
Relypsa
——
David Nierengarten63%
→ $51MaintainsOutperformGet Alert
05/31/2016NTLABuy Now
Intellia Therapeutics
$9.20—
David Nierengarten63%
—Initiates → OutperformGet Alert
05/11/2016EPRSBuy Now
EPIRUS Biopharmaceuticals
——
David Nierengarten63%
—DowngradeOutperform → NeutralGet Alert
03/30/2016ONCEBuy Now
Spark Therapeutics
——
David Nierengarten63%
→ $21Initiates → UnderperformGet Alert
01/20/2016TSROBuy Now
Tesaro
——
David Nierengarten63%
→ $72Initiates → OutperformGet Alert
11/23/2015MYOKBuy Now
MyoKardia
——
David Nierengarten63%
→ $22Initiates → OutperformGet Alert
10/27/2015NVCRBuy Now
NovoCure
$19.3654.96%
David Nierengarten63%
→ $30Initiates → OutperformGet Alert
10/07/2014KPTIBuy Now
Karyopharm Therapeutics
$5.83757.63%
David Nierengarten63%
→ $750Initiates → OutperformGet Alert
10/28/2013FATEBuy Now
Fate Therapeutics
$0.951373.53%
David Nierengarten63%
→ $14Initiates → OutperformGet Alert
10/25/2013PRTABuy Now
Prothena Corp
$12.93147.49%
David Nierengarten63%
$18 → $32MaintainsOutperformGet Alert
09/12/2013STMLBuy Now
Stemline Therapeutics
——
David Nierengarten63%
→ $49Initiates → OutperformGet Alert
09/11/2013STMLBuy Now
Stemline Therapeutics
——
David Nierengarten63%
→ $49Initiates → OutperformGet Alert
06/27/2013PRTABuy Now
Prothena Corp
$12.9339.21%
David Nierengarten63%
→ $18Initiates → OutperformGet Alert
06/27/2013EPZMBuy Now
Epizyme
——
David Nierengarten63%
→ $37Initiates → OutperformGet Alert
03/27/2013ECYTBuy Now
Endocyte, Inc.
——
David Nierengarten63%
$16 → $20MaintainsOutperformGet Alert